Interestingly, inflammatory response, the NFκB signaling pathway and cell cycle pathways such as E2F targets have already been found to be correlated with the oncogenesis and progression of AML [45,46,47,48]. The gene discussed is NFKB1; the disease is acute myeloid leukemia.